ArticleFrontiers in immunology2026
Pretreatment CT radiomics for prediction of pathological complete response after neoadjuvant chemoimmunotherapy in NSCLC: a multicenter study incorporating habitat analysis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pathological complete response (pCR) after neoadjuvant chemoimmunotherapy (NACI) varies among patients with non-small cell lung cancer (NSCLC). This study aimed to quantify intratumoral heterogeneity using habitat analysis and to develop a pretreatment model for predicting pCR. Methods: In this retrospective multicenter study, 287 patients with NSCLC who received NACI followed by surgery were included. Patients were randomly divided into a training cohort (n = 147) and an internal validation cohort (n = 63), with an independent external test cohort (n = 77). K-means clustering was used to partition tumors into three habitat subregions based on entropy. Radiomics features were extracted from pretreatment CT images at the whole-tumor and habitat levels. Whole-tumor, habitat-based, and combined models were developed to predict pCR. Model performance was evaluated using area under the curve (AUC) analysis, and model interpretability was assessed using Shapley Additive exPlanations (SHAP). Results: The habitat-based model showed acceptable predictive performance across the training, internal validation, and external test cohorts, with AUCs of 0.74, 0.71, and 0.67, respectively, and showed higher AUCs compared with the whole-tumor radiomics model, which achieved AUCs of 0.72, 0.68, and 0.65. The combined model achieved performance comparable to the habitat-based model. SHAP analysis suggested that, among the habitat-derived features, the most influential predictive features were primarily associated with the high-entropy habitat subregion. Conclusion: The habitat-based model shows potential performance for predicting pCR, and features from a high-entropy habitat subregion may provide complementary imaging information for preoperative assessment of treatment response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.